--- title: "DHSC:OLS_Liquid Biopsy Testing and its Impact in Primary Care" ocid: "ocds-h6vhtk-054960" canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-054960" markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-054960.md" json_url: "https://d3tenders.com/contract/ocds-h6vhtk-054960.json" source: "Find A Tender Service" current_stage: "Planning" buyer: "DHSC, LONDON" published: "2025-06-25" --- # DHSC:OLS_Liquid Biopsy Testing and its Impact in Primary Care Buyer: DHSC, LONDON Current stage: Planning OCID: ocds-h6vhtk-054960 [View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-054960) [Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-054960.json) ## Summary The Department of Health and Social Care (DHSC), London, in collaboration with the Office for Life Sciences (OLS), is planning a procurement process titled "DHSC:OLS_Liquid Biopsy Testing and its Impact in Primary Care". This initiative falls under services in the research and development consultancy, medical equipment, and medical laboratory services categories, with a focus on the clinical impact of liquid biopsy tests for early cancer diagnosis in patients with abdominal symptoms. The planning stage is currently underway, with a milestone scheduled for 7th July 2025, requesting completed questionnaires to be submitted via email. The procurement process, intended as a tripartite consortium, aims to begin in October 2025 and conclude by March 2027, engaging liquid biopsy providers for use in NHS settings across the UK. This procurement process presents significant opportunities for businesses in the healthcare and research sectors, particularly those with expertise in cancer diagnostics and therapeutic technologies. Small and medium-sized enterprises (SMEs) with capabilities in liquid biopsy development and those able to partner with independent evaluators and NHS sites will find this tender particularly relevant. By participating, businesses can contribute to shaping future funding competitions under the OLS’s Cancer Healthcare Goals programme. Engaging in this procurement not only positions businesses as leaders in innovative cancer diagnostic solutions but also allows them to influence and benefit from a sizable contract intended to advance medical technology evaluation frameworks. ## Notice DHSC (Department of Health) and OLS (Office for Life Sciences) is seeking to commission a supplier that will conduct a research project to understand the clinical impact of liquid biopsy tests on the early diagnosis of cancer in symptomatic patients presenting with abdominal symptoms in primary care. We anticipate that delivery will require a tripartite consortium comprising an independent evaluator and a liquid biopsy provider, with the capability to identify, establish, and manage engagement with point-of-care settings (NHS) for patient recruitment and participation. The Office for Life Sciences seeks to run a market engagement to assess the number of liquid biopsy providers with diagnostic tests at a later stage of development, with published evidence of efficacy in patients with suspected cancer symptoms. This research project would act as a use case for the OLS' Cancer Healthcare Goals programme when developing future funding competitions which aim to address a market failure in the evaluation of cancer diagnostic and therapeutic technologies in the latter stages of development. This initial market questionnaire aims to, at a high level, understand the scale, knowledge and capability of the market along with what appetite there is for delivering this service. DHSC/OLS would like to use this market engagement to inform the specification for commissioning a supplier for what is an anticipated 18-month contract. This is not a call for competition, but an opportunity to gather feedback to better understand market capabilities, refine the procurement strategy, and encourage supplier engagement. Interested parties can access the relevant documents via the Atamis system at https://health-family.force.com/s/Welcome using the contract reference. Suppliers may also submit the completed questionnaire through Atamis but must be registered on the system to do so. Alternatively, questionnaires can be submitted by email to ccsinbox@dhsc.gov.uk, quoting "Liquid Biopsy" no later than 07/07/2025 5pm ### Planning Information The completed questionnaire as part of the documents should be returned via email ccsinbox@dhsc.gov.uk quoting “PME Liquid Biopsy” no later than 07/07/2025 at 5pm ## Key Details | Field | Value | | --- | --- | | Publication source | Find A Tender Service | | Latest notice | https://www.find-tender.service.gov.uk/Notice/035152-2025 | | Notice type | UK2 - Preliminary Market Engagement Notice | | Procurement type | Standard | | Procurement category | Services | | Procurement method | Not Specified | | Procurement method details | Not specified | | Tender suitability | SME | | Awardee scale | Not specified | | All stages | Planning | ## Dates | Field | Value | | --- | --- | | Publication date | 25 Jun 2025 | | Submission deadline | Not specified | | Future notice date | 7 Jul 2025 | | Award date | Not specified | | Contract period | 30 Sep 2025 - 31 Mar 2027 | | Recurrence | Not specified | ## Values | Field | Value | | --- | --- | | Tender value | Not specified | | Lots value | Not specified | | Awards value | Not specified | | Contracts value | Not specified | ## Status | Field | Value | | --- | --- | | Tender status | Planning | | Lots status | Planning | | Awards status | Not specified | | Contracts status | Not specified | ## Buyer | Field | Value | | --- | --- | | Main buyer | DHSC, LONDON | | Locality | LONDON | | Post town | South West London | | Postcode | SW1H 0EU | | Country | England | | ITL 1 | TLI London | | ITL 2 | TLI3 Inner London - West | | ITL 3 | TLI35 Westminster and City of London | | Local authority | Westminster | | Electoral ward | St James's | | Westminster constituency | Cities of London and Westminster | | Delivery location | Not specified | ## CPV Codes ### Divisions - 33 - Medical equipments, pharmaceuticals and personal care products - 73 - Research and development services and related consultancy services - 85 - Health and social work services ### Codes - 33000000 - Medical equipments, pharmaceuticals and personal care products - 73110000 - Research services - 73200000 - Research and development consultancy services - 85145000 - Services provided by medical laboratories ## Release History - 25 Jun 2025 at 14:41 - PlanningUpdate - UK2 - Preliminary Market Engagement Notice - https://www.find-tender.service.gov.uk/Notice/035152-2025 - 16 Jun 2025 at 13:48 - Planning - UK2 - Preliminary Market Engagement Notice - https://www.find-tender.service.gov.uk/Notice/032641-2025 ## Documents - https://www.find-tender.service.gov.uk/Notice/035152-2025 25th June 2025 - Preliminary market engagement notice on Find a Tender - https://www.find-tender.service.gov.uk/Notice/032641-2025 16th June 2025 - Preliminary market engagement notice on Find a Tender ## Notice URLs - https://health-family.force.com/s/Welcome - https://www.gov.uk/government/organisations/department-of-health-and-social-care - https://www.legislation.gov.uk/ukpga/2023/54/contents ## Provenance This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-054960. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-054960.json.